Release Date: 21/02/12 18:11 Summary: Option Issue and Appendix 3B Price Sensitive: No Download Document 644.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%